Cargando…
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
The development of animal models for COVID-19 is essential for basic research and drug/vaccine screening. Previously reported COVID-19 animal models need to be established under a high biosafety level condition for the utilization of live SARS-CoV-2, which greatly limits its application in routine r...
Autores principales: | Bi, Zhenfei, Hong, Weiqi, Que, Haiying, He, Cai, Ren, Wenyan, Yang, Jingyun, Lu, Tianqi, Chen, Li, Lu, Shuaiyao, Peng, Xiaozhong, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705082/ https://www.ncbi.nlm.nih.gov/pubmed/34952899 http://dx.doi.org/10.1038/s41392-021-00851-6 |
Ejemplares similares
-
A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
por: Hong, Weiqi, et al.
Publicado: (2021) -
Animal models for SARS‐CoV‐2 infection and pathology
por: Bi, Zhenfei, et al.
Publicado: (2021) -
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
por: Que, Haiying, et al.
Publicado: (2022) -
Neurological complications and infection mechanism of SARS-CoV-2
por: Wan, Dandan, et al.
Publicado: (2021) -
TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway
por: Lu, Tianqi, et al.
Publicado: (2023)